From January 1, 2024 to March 31, 2024, the company has repurchased 230,200 shares, representing 0.02% for CNY 7 million. With this, the company has completed the repurchase of 961,700 shares, representing 0.1% for CNY 27.09 million under the buyback announced on July 4, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
41.14 CNY | +2.34% | -2.70% | +30.89% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+30.89% | 5.24B | |
+33.25% | 704B | |
+28.59% | 577B | |
-3.55% | 348B | |
+18.16% | 327B | |
+4.36% | 288B | |
+14.81% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-3.69% | 147B |
- Stock Market
- Equities
- 600566 Stock
- News Hubei Jumpcan Pharmaceutical Co., Ltd.
- Tranche Update on Hubei Jumpcan Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 4, 2023.